Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Cancer Treatment and Research
|
October 4, 2016
Bone Disease in Multiple Myeloma
Homare Eda, Loredana Santo, G David Roodman, et al.
Biochemical and Biophysical Research Communications
|
December 11, 2007
FGF-2 signaling induces downregulation of TAZ protein in osteoblastic MC3T3-E1 cells
Homare Eda, Katsuhiko Aoki, Keishi Marumo, et al.
JBMR Plus
|
November 18, 2022
TRACP-5b/BAP Score After 3 Months of Treatment With Combined SERM/E2 Therapy Can Predict Changes in Lumbar Spine Bone Mineral Density After 1 Year of Treatment in Early Postmenopausal Osteopenia
Ikuko Ota, Yoshiaki Ota, Kuniaki Ota, et al.
European Journal of Haematology
|
March 3, 2010
The proteasome inhibitor bortezomib inhibits FGF-2-induced reduction of TAZ levels in osteoblast-like cells
Homare Eda, Katsuhiko Aoki, Soki Kato, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
November 20, 2014
Role of decorin in multiple myeloma (MM) bone marrow microenvironment
Neeharika Nemani, Loredana Santo, Homare Eda, et al.
International Journal of Oncology
|
April 11, 2009
Three-dimensional culture using a radial flow bioreactor induces matrix metalloprotease 7-mediated EMT-like process in tumor cells via TGFbeta1/Smad pathway
Shun-Ichi Shibata, Hideki Marushima, Tadashi Asakura, et al.
The Journal of Clinical Investigation
|
March 2, 2016
Endogenous transmembrane protein UT2 inhibits pSTAT3 and suppresses hematological malignancy
Dongjun Lee, Ying-Hua Wang, Demetrios Kalaitzidis, et al.
International Journal of Oncology
|
July 26, 2011
Three-dimensional culture promotes reconstitution of the tumor-specific hypoxic microenvironment under TGFβ stimulation
Hideki Marushima, Shun-Ichi Shibata, Tadashi Asakura, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
January 15, 2016
Regulation of Sclerostin Expression in Multiple Myeloma by Dkk-1: A Potential Therapeutic Strategy for Myeloma Bone Disease
Homare Eda, Loredana Santo, Marc N Wein, et al.
Molecular Cancer Therapeutics
|
August 31, 2014
Delineating the mTOR kinase pathway using a dual TORC1/2 inhibitor, AZD8055, in multiple myeloma
Diana Cirstea, Loredana Santo, Teru Hideshima, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Cancer Treatment and Research
|
October 4, 2016
Bone Disease in Multiple Myeloma
Homare Eda, Loredana Santo, G David Roodman, et al.
Biochemical and Biophysical Research Communications
|
December 11, 2007
FGF-2 signaling induces downregulation of TAZ protein in osteoblastic MC3T3-E1 cells
Homare Eda, Katsuhiko Aoki, Keishi Marumo, et al.
JBMR Plus
|
November 18, 2022
TRACP-5b/BAP Score After 3 Months of Treatment With Combined SERM/E2 Therapy Can Predict Changes in Lumbar Spine Bone Mineral Density After 1 Year of Treatment in Early Postmenopausal Osteopenia
Ikuko Ota, Yoshiaki Ota, Kuniaki Ota, et al.
European Journal of Haematology
|
March 3, 2010
The proteasome inhibitor bortezomib inhibits FGF-2-induced reduction of TAZ levels in osteoblast-like cells
Homare Eda, Katsuhiko Aoki, Soki Kato, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
November 20, 2014
Role of decorin in multiple myeloma (MM) bone marrow microenvironment
Neeharika Nemani, Loredana Santo, Homare Eda, et al.
International Journal of Oncology
|
April 11, 2009
Three-dimensional culture using a radial flow bioreactor induces matrix metalloprotease 7-mediated EMT-like process in tumor cells via TGFbeta1/Smad pathway
Shun-Ichi Shibata, Hideki Marushima, Tadashi Asakura, et al.
The Journal of Clinical Investigation
|
March 2, 2016
Endogenous transmembrane protein UT2 inhibits pSTAT3 and suppresses hematological malignancy
Dongjun Lee, Ying-Hua Wang, Demetrios Kalaitzidis, et al.
International Journal of Oncology
|
July 26, 2011
Three-dimensional culture promotes reconstitution of the tumor-specific hypoxic microenvironment under TGFβ stimulation
Hideki Marushima, Shun-Ichi Shibata, Tadashi Asakura, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
January 15, 2016
Regulation of Sclerostin Expression in Multiple Myeloma by Dkk-1: A Potential Therapeutic Strategy for Myeloma Bone Disease
Homare Eda, Loredana Santo, Marc N Wein, et al.
Molecular Cancer Therapeutics
|
August 31, 2014
Delineating the mTOR kinase pathway using a dual TORC1/2 inhibitor, AZD8055, in multiple myeloma
Diana Cirstea, Loredana Santo, Teru Hideshima, et al.
Page
of 2